meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1464-410X.2001.02141.X |
P8608 | Fatcat ID | release_dres3p4i2ne5bdjnsrfvyc572i |
P698 | PubMed publication ID | 11350402 |
P50 | author | Padraig Warde | Q48044256 |
P2093 | author name string | C C Parker | |
M Gospodarowicz | |||
P2860 | cites work | Primary treatment choices for men with clinically localized prostate carcinoma detected by screening | Q46977038 |
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. | Q52418332 | ||
Results of conservative management of clinically localized prostate cancer. | Q52884523 | ||
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor. | Q52903987 | ||
Localized prostate cancer in elderly patients. Outcome after radiation therapy compared to matched younger patients. | Q53536411 | ||
Results of radical prostatectomy in men with clinically localized prostate cancer | Q34393990 | ||
Natural History and Prognosis of Prostate Carcinoma in Adolescents and Men under 35 Years of Age | Q36289915 | ||
Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey | Q36652069 | ||
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment | Q36884863 | ||
Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom | Q38633306 | ||
Deferred treatment of localized prostate cancer in the elderly: the impact of the age and stage at the time of diagnosis on the treatment decision | Q39534056 | ||
Cancer of the prostate. Do younger men have a poorer survival rate? | Q40226006 | ||
Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients. | Q40700601 | ||
The relationship between biochemical failure and time to nadir in patients treated with external beam therapy for T1-T3 prostate carcinoma | Q40838811 | ||
A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma | Q40907007 | ||
Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system | Q41659782 | ||
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients | Q43201975 | ||
P433 | issue | 7 | |
P304 | page(s) | 629-637 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | BJU International | Q4835773 |
P1476 | title | Does age influence the behaviour of localized prostate cancer? | |
P478 | volume | 87 |
Q46282060 | A 43-year-old African American man with low-risk prostate cancer |
Q78688136 | Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma |
Q46661409 | Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings |
Q81780919 | Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer |
Q57566962 | Cancer de la prostate |
Q87176751 | Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger |
Q35123237 | Contemporary pathology of prostate cancer |
Q44536250 | Controversial predictors of biochemical recurrence after radical prostatectomy: a study from a Latin American (Brazilian) institution |
Q37375491 | Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts |
Q40586543 | Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy |
Q38873431 | High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer |
Q36746831 | Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC). |
Q38835014 | Is Age an Independent Factor for Prostate Cancer? A Paired Analysis |
Q36361706 | Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials |
Q36103672 | Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales |
Q28388487 | Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond |
Q35108252 | Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future |
Q39925854 | Survival and prognostic factors of patients with clinically localized prostate cancer |
Q36034209 | The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer |
Search more.